Effects of Early Rituximab Retreatment in Rheumatoid Arthritis Patients with an Inadequate Response After the First Cycle: Retrospective Arthritis Cohort Study

被引：9

作者：

Bastian, Hans ^{[1
]}

Zinke, Silke ^{[2
]}

Egerer, Karl ^{[1
]}

Breuer, Steffen ^{[3
]}

Safari, Frank ^{[3
]}

Burmester, Gerd-Ruediger ^{[1
]}

Feist, Eugen ^{[1
]}

机构：

[1] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany

[2] Rheumatol Off, Berlin, Germany

[3] Roche Pharma AG, Grenzach Wyhlen, Germany

来源：

JOURNAL OF RHEUMATOLOGY | 2010年 / 37卷 / 05期

关键词：

DOUBLE-BLIND; EFFICACY; SAFETY; TRIAL;

D O I：

10.3899/jrheum.091127

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1069 / 1072

页数：4

共 4 条

[1] Epidemiology of adult rheumatoid arthritis [J].

Alamanos, Y ;

Drosos, AA .

AUTOIMMUNITY REVIEWS, 2005, 4 (03) :130-136

[2] Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[3] Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes [J].

Edwards, JCW ;

Cambridge, G .

RHEUMATOLOGY, 2001, 40 (02) :205-211

[4] The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial [J].

Emery, P ;

Fleischmann, R ;

Filipowicz-Sosnowska, A ;

Schechtman, J ;

Szczepanski, L ;

Kavanaugh, A ;

Racewicz, AJ ;

Van Vollenhoven, RF ;

Li, NF ;

Agarwal, S ;

Hessey, EW ;

Shaw, TM .

ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1390-1400

← 1 →